Effectiveness of different oncolytic vaccinia virus strains for the in vitro and in vivo treatment of peritoneal mesothelioma

被引：0
|
作者：
Yurttas, Can [1 ,2 ]
Beil, Julia [2 ,3 ,4 ]
Susanne, Berchtold [2 ,3 ]
Smirnow, Irina [2 ,3 ]
Kloker, Linus D. [2 ,3 ]
Sipos, Bence [3 ,4 ,5 ]
Koenigsrainer, Alfred [1 ,4 ]
Mihaljevic, Andre [1 ]
Lauer, Ulrich [2 ,3 ,4 ]
Thiel, Karolin [1 ]
机构：
[1] Univ Hosp Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany
[2] Univ Hosp Tubingen, Dept Med Oncol & Pneumol, Virotherapy Ctr Tubingen VCT, Tubingen, Germany
[3] Univ Hosp Tubingen, Dept Internal Med Med Oncol & Pneumol 8, Tubingen, Germany
[4] German Canc Res Ctr, Partner Site Tubingen, German Canc Consortium DKTK, Tubingen, Germany
[5] BAG Pathol & Mol Pathol Stuttgart, Stuttgart, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
595
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [21] Recombinant chimeric horsepox virus (TNX-801) is attenuated relative to vaccinia virus strains in both in vitro and in vivo models
    Trefry, Stephanie V.
    Awasthi, Mayanka
    Raney, Christy N.
    Cregger, Amy L.
    Gonzales, Chase A.
    Layton, Brittney L.
    Enamorado, Robert N.
    Martinez, Nelson A.
    Gohegan, Deborah S.
    Masoud-Bahnamiri, Masoudeh
    Cho, Jennifer Y.
    Myscofski, Dawn M.
    Moulaei, Tinoush
    Ziolkowska, Natasza E.
    Goebel, Scott J.
    Lederman, Seth
    Bavari, Sina
    Nasar, Farooq
    MSPHERE, 2024, 9 (12)
  • [22] High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma
    Delaunay, Tiphaine
    Nader, Joelle
    Grard, Marion
    Farine, Isabelle
    Hedwig, Vera
    Foloppe, Johann
    Blondy, Thibaut
    Violland, Mathilde
    Pouliquen, Daniel
    Gregoire, Marc
    Boisgerault, Nicolas
    Erbs, Philippe
    Fonteneau, Jean-Francois
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 573 - 578
  • [23] Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis
    Lauer, Ulrich M.
    Schell, Martina
    Beil, Julia
    Berchtold, Susanne
    Koppenhoefer, Ursula
    Glatzle, Joerg
    Koenigsrainer, Alfred
    Moehle, Robert
    Nann, Dominik
    Fend, Falko
    Pfannenberg, Christina
    Bitzer, Michael
    Malek, Nisar P.
    CLINICAL CANCER RESEARCH, 2018, 24 (18) : 4388 - 4398
  • [24] Beclin1-armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R-CHOP against lymphoma in vitro and in vivo
    Xie, Shufang
    Fan, Weimin
    Yang, Chen
    Lei, Wen
    Pan, Hongying
    Tong, Xiangmin
    Wu, Yi
    Wang, Shibing
    ONCOLOGY REPORTS, 2021, 45 (03) : 987 - 996
  • [25] Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy
    Wu, Heliang
    Wang, Yi
    Lin, Yulin
    Ma, Ru
    Du, Xuemei
    Su, Yandong
    Yang, Rui
    Yang, Zhiran
    Liang, Xinli
    Zhang, Yinguang
    Liang, Xiaoqing
    Ji, Zhonghe
    Lai, Chunning
    Huang, Yajing
    Li, Yan
    CANCER BIOLOGY & MEDICINE, 2024, 21 (11) : 1078 - 1094
  • [26] Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy
    Heliang Wu
    Yi Wang
    Yulin Lin
    Ru Ma
    Xuemei Du
    Yandong Su
    Rui Yang
    Zhiran Yang
    Xinli Liang
    Yinguang Zhang
    Xiaoqing Liang
    Zhonghe Ji
    Chunning Lai
    Yajing Huang
    Yan Li
    Cancer Biology & Medicine, 2024, 21 (11) : 1078 - 1094
  • [27] Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
    Ghose, Jayeeta
    Dona, Ada
    Murtadha, Mariam
    Gunes, Emine Gulsen
    Caserta, Enrico
    Yoo, Ji Young
    Russell, Luke
    Jaime-Ramirez, Alena Cristina
    Barwick, Benjamin G.
    Gupta, Vikas A.
    Sanchez, James F.
    Sborov, Douglas W.
    Rosen, Steven T.
    Krishnan, Amrita
    Boise, Lawrence H.
    Kaur, Balveen
    Hofmeister, Craig C.
    Pichiorri, Flavia
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 : 519 - 531
  • [28] The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell Mediated Immune Compartments In Vivo
    de Freitas, Lorena F. D.
    Oliveira, Rafael P.
    Miranda, Mariana C. G.
    Rocha, Raissa P.
    Barbosa-Stancioli, Edel F.
    Faria, Ana Maria C.
    da Fonseca, Flavio G.
    JOURNAL OF VIROLOGY, 2019, 93 (06)
  • [29] Oncolytic vaccinia virus GL-ONC1 treatment of colorectal cancer patients
    Reinboth, J.
    Ralph, C.
    Sciagalla, P.
    Yu, Y. A.
    Agular, J.
    Chen, N.
    Szalay, A.
    Melcher, A. A.
    West, E. J.
    HUMAN GENE THERAPY, 2014, 25 (12) : A26 - A26
  • [30] Engineering Neutralization-Resistant Oncolytic Vaccinia Virus for Effective Treatment of Multiple Myeloma
    Zhou, Li
    Song, Xiaotong
    Zhai, Zhimin
    BLOOD, 2024, 144
12345